Macrophages in the Aging Liver and Age-Related Liver Disease

The number of individuals aged 65 or older is projected to increase globally from 524 million in 2010 to nearly 1. 5 billion in 2050. Aged individuals are particularly at risk for developing chronic illness, while being less able to regenerate healthy tissue and tolerate whole organ transplantation...

Full description

Bibliographic Details
Main Authors: Elizabeth C. Stahl, Martin J. Haschak, Branimir Popovic, Bryan N. Brown
Format: Article
Language:English
Published: Frontiers Media S.A. 2018-11-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fimmu.2018.02795/full
_version_ 1818139049489072128
author Elizabeth C. Stahl
Martin J. Haschak
Branimir Popovic
Bryan N. Brown
author_facet Elizabeth C. Stahl
Martin J. Haschak
Branimir Popovic
Bryan N. Brown
author_sort Elizabeth C. Stahl
collection DOAJ
description The number of individuals aged 65 or older is projected to increase globally from 524 million in 2010 to nearly 1. 5 billion in 2050. Aged individuals are particularly at risk for developing chronic illness, while being less able to regenerate healthy tissue and tolerate whole organ transplantation procedures. In the liver, these age-related diseases include non-alcoholic fatty liver disease, alcoholic liver disease, hepatitis, fibrosis, and cirrhosis. Hepatic macrophages, a population comprised of both Kupffer cells and infiltrating monocyte derived macrophages, are implicated in several chronic liver diseases and also play important roles in the homeostatic functions of the liver. The effects of aging on hepatic macrophage population dynamics, polarization, and function are not well understood. Studies performed on macrophages derived from other aged sources, such as the bone marrow, peritoneal cavity, lungs, and brain, demonstrate general reductions in autophagy and phagocytosis, dysfunction in cytokine signaling, and altered morphology and distribution, likely mediated by epigenetic changes and mitochondrial defects, that may be applicable to hepatic macrophages. This review highlights recent findings in macrophage developmental biology and function, particularly in the liver, and discusses the role of macrophages in various age-related liver diseases. A better understanding of the biology of aging that influences hepatic macrophages and thus the progression of chronic liver disease will be crucial in order to develop new interventions and treatments for liver disease in aging populations.
first_indexed 2024-12-11T10:21:55Z
format Article
id doaj.art-3b5c71c18a3645e3a2cf0ffe73ce515f
institution Directory Open Access Journal
issn 1664-3224
language English
last_indexed 2024-12-11T10:21:55Z
publishDate 2018-11-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Immunology
spelling doaj.art-3b5c71c18a3645e3a2cf0ffe73ce515f2022-12-22T01:11:22ZengFrontiers Media S.A.Frontiers in Immunology1664-32242018-11-01910.3389/fimmu.2018.02795422500Macrophages in the Aging Liver and Age-Related Liver DiseaseElizabeth C. StahlMartin J. HaschakBranimir PopovicBryan N. BrownThe number of individuals aged 65 or older is projected to increase globally from 524 million in 2010 to nearly 1. 5 billion in 2050. Aged individuals are particularly at risk for developing chronic illness, while being less able to regenerate healthy tissue and tolerate whole organ transplantation procedures. In the liver, these age-related diseases include non-alcoholic fatty liver disease, alcoholic liver disease, hepatitis, fibrosis, and cirrhosis. Hepatic macrophages, a population comprised of both Kupffer cells and infiltrating monocyte derived macrophages, are implicated in several chronic liver diseases and also play important roles in the homeostatic functions of the liver. The effects of aging on hepatic macrophage population dynamics, polarization, and function are not well understood. Studies performed on macrophages derived from other aged sources, such as the bone marrow, peritoneal cavity, lungs, and brain, demonstrate general reductions in autophagy and phagocytosis, dysfunction in cytokine signaling, and altered morphology and distribution, likely mediated by epigenetic changes and mitochondrial defects, that may be applicable to hepatic macrophages. This review highlights recent findings in macrophage developmental biology and function, particularly in the liver, and discusses the role of macrophages in various age-related liver diseases. A better understanding of the biology of aging that influences hepatic macrophages and thus the progression of chronic liver disease will be crucial in order to develop new interventions and treatments for liver disease in aging populations.https://www.frontiersin.org/article/10.3389/fimmu.2018.02795/fullKupffer cellmonocyte-derived macrophagechronic liver diseaseinflammationfibrosissenescence
spellingShingle Elizabeth C. Stahl
Martin J. Haschak
Branimir Popovic
Bryan N. Brown
Macrophages in the Aging Liver and Age-Related Liver Disease
Frontiers in Immunology
Kupffer cell
monocyte-derived macrophage
chronic liver disease
inflammation
fibrosis
senescence
title Macrophages in the Aging Liver and Age-Related Liver Disease
title_full Macrophages in the Aging Liver and Age-Related Liver Disease
title_fullStr Macrophages in the Aging Liver and Age-Related Liver Disease
title_full_unstemmed Macrophages in the Aging Liver and Age-Related Liver Disease
title_short Macrophages in the Aging Liver and Age-Related Liver Disease
title_sort macrophages in the aging liver and age related liver disease
topic Kupffer cell
monocyte-derived macrophage
chronic liver disease
inflammation
fibrosis
senescence
url https://www.frontiersin.org/article/10.3389/fimmu.2018.02795/full
work_keys_str_mv AT elizabethcstahl macrophagesintheagingliverandagerelatedliverdisease
AT martinjhaschak macrophagesintheagingliverandagerelatedliverdisease
AT branimirpopovic macrophagesintheagingliverandagerelatedliverdisease
AT bryannbrown macrophagesintheagingliverandagerelatedliverdisease